Key takeaways
Highmark insurance may cover Wegovy for weight loss, depending on your specific plan.
If your plan covers Wegovy for weight loss, you’ll typically need prior authorization before Highmark will pay for it.
What you pay out-of-pocket depends on your plan, deductible, and copay or coinsurance. Checking your plan’s drug formulary is the fastest way to see what applies to you.
Here's what we'll cover
Here's what we'll cover
Here's what we'll cover
Key takeaways
Highmark insurance may cover Wegovy for weight loss, depending on your specific plan.
If your plan covers Wegovy for weight loss, you’ll typically need prior authorization before Highmark will pay for it.
What you pay out-of-pocket depends on your plan, deductible, and copay or coinsurance. Checking your plan’s drug formulary is the fastest way to see what applies to you.
Insurance coverage for GLP-1 medications can get confusing fast. Two people covered by the same insurance company may have completely different coverage depending on their plan, employer, and why the medication was prescribed. So, does Highmark cover Wegovy for weight loss?
It depends. Some Highmark plans cover Wegovy (semaglutide) for weight loss, while others exclude weight loss medications altogether. Here’s how to find out what your plan covers, what you might pay, and what to do if your plan won’t cover Wegovy.
Does Highmark cover Wegovy for weight loss?
Yes, some Highmark insurance covers Wegovy for weight loss, but it depends on your specific benefits.
For Highmark commercial plans (which may be branded either Highmark Blue Cross Blue Shield or Highmark Blue Shield, depending on where you live), coverage generally depends on whether your plan includes weight loss medications and whether you meet certain criteria to qualify.
Highmark may consider factors like:
Age
Body mass index (BMI)
Diagnosed weight-related health conditions
Documented previous efforts to manage your weight through diet and physical activity
Insurance plans also typically require prior authorization, meaning your healthcare provider will need to get approval from Highmark before your plan covers the medication. Some plans also prefer to cover Zepbound (tirzepatide), a related weight loss medication, so you may need a medical reason you can’t take Zepbound before Highmark will cover Wegovy.
Does Highmark cover Wegovy for heart disease and fatty liver disease?
Potentially. Wegovy is also approved by the US Food and Drug Administration (FDA) to lower the risk of heart attack, stroke, and death due to heart disease in adults with cardiovascular disease and overweight or obesity. In fact, a large clinical trial found that semaglutide reduced the risk of these major cardiovascular events by 20% compared with placebo.
Another FDA-approved use for Wegovy is to treat metabolic dysfunction-associated steatohepatitis (MASH), a serious form of fatty liver disease, in adults with moderate-to-advanced liver fibrosis. Another clinical trial found that about 63% of people taking semaglutide saw their MASH resolve without worsening liver scarring, compared with 34% taking a placebo.
Highmark commercial plans have separate coverage criteria for Wegovy when it’s prescribed for cardiovascular risk reduction or MASH. That means your plan may cover Wegovy for one of these conditions even if it doesn’t cover the medication for weight loss.
Yes, most Highmark commercial and Medicare plans typically require prior authorization for Wegovy. This means your healthcare provider will need to submit information showing that you meet your plan’s coverage requirements before Highmark will cover the medication.
For Wegovy for weight loss, that may include documentation of your:
Age
BMI
Diagnosed weight-related health conditions
Documented previous efforts to manage your weight through diet and physical activity
Depending on your plan, your provider may also need to show why a preferred medication, such as Zepbound, isn’t appropriate for you.
Prior authorization may also be required when Wegovy is prescribed for cardiovascular risk reduction or for MASH, though the criteria differ. Depending on your condition, Highmark may look for documentation such as:
For cardiovascular risk reduction: Established cardiovascular disease plus overweight or obesity
For MASH: A confirmed MASH diagnosis and evidence of moderate-to-advanced liver fibrosis
If Highmark approves your request, keep in mind that the approval may only last for a set period and quantity limits apply. Depending on your plan, your provider may need to request another authorization at a later date to maintain coverage. You will also likely pay a higher, Tier 3 copay if Wegovy is considered a non-preferred brand on your Highmark plan.
How to check if your Highmark plan covers Wegovy for weight loss
Because Highmark coverage varies by plan, the best way to know where you stand is to check your specific benefits. Here are a few ways to do that:
1. Check your formulary. Your plan’s formulary — or covered drug list — can tell you whether Wegovy is covered and whether requirements like prior authorization apply.
2. Log in to your Highmark account. Your member portal can provide coverage and cost information specific to your plan.
3. Call the number on your insurance card. Ask whether Wegovy is covered for weight loss under your plan, whether you’ll need prior authorization, and whether you qualify.
4. Ask your healthcare provider. Your provider can help check your coverage and, if necessary, submit a prior authorization request with the required medical information.
5. Use Ro’s free GLP-1 Insurance Coverage Checker. Simply enter your plan information, and Ro will contact your insurer to check your coverage for certain GLP-1s. You’ll receive a personalized report explaining your coverage, potential costs, and whether prior authorization is required.
6. Tap Ro’s insurance concierge. If you’re a Ro Body member, the insurance concierge can work directly with your insurer to check coverage and handle paperwork, including submitting prior authorization if needed.
How much does Wegovy cost?
Wegovy has a list price of $1,349.02 per package, though you can often pay less with insurance or by paying cash through Ro. If your commercial insurance covers Wegovy, the manufacturer savings offer can bring your copay down to as little as $25 per month.
If you’re paying cash, you can get Wegovy on Ro for the following prices* (if prescribed):
Wegovy pill: $149–$299 per month, depending on the dose
Wegovy pen: $199–$399 per month, depending on the dose
*Prices may reflect limited-time offers and are subject to change; see more here.
What to do if Highmark won’t cover Wegovy
If Highmark denies coverage for Wegovy, don’t worry — you still have options. Depending on why it was denied, you may be able to:
Pay out of pocket for Wegovy. If insurance won’t cover Wegovy, you may be able to pay cash through Ro. At the time of this writing, new patients can start Wegovy for as low as $149 per month (if prescribed).
Appeal the decision. Your healthcare provider can help submit an appeal with additional medical information explaining why Wegovy is appropriate for you.
Ask about other covered medications. Your plan may cover another weight loss medication, such as Zepbound or Foundayo (orforglipron), even if it doesn’t cover Wegovy.
Review your options during open enrollment. If your current plan excludes weight loss medications altogether, you may be able to choose a plan with different coverage for the following year.
If your insurance stops covering Wegovy after you’ve already started treatment, talk to your healthcare provider before making any changes. They can help you figure out whether an appeal, another medication, or a different payment option makes sense.
Bottom line
Highmark may cover Wegovy, but the details come down to your specific plan and why you’re taking the medication. Here’s what to remember:
Some Highmark plans cover Wegovy for weight loss, while others exclude weight loss medications.
Prior authorization is typically required, and you’ll need to meet your plan’s coverage criteria.
Highmark may cover Wegovy for cardiovascular risk reduction or MASH even if your plan doesn’t cover it for weight loss.
If Wegovy isn’t covered, you may be able to appeal the decision, ask about another covered medication, or explore savings programs to lower the out-of-pocket cost.
Frequently asked questions (FAQs)
Does Highmark cover weight Ozempic for weight loss?
Highmark generally does not cover Ozempic when it’s prescribed solely for weight loss.
Ozempic (semaglutide) is FDA-approved for people with type 2 diabetes, while Wegovy contains the same active ingredient but is approved for weight management. Highmark’s GLP-1 coverage policy states that drugs such as Ozempic won’t be approved for a sole diagnosis of obesity, though your exact coverage depends on your plan.
Does Highmark Wholecare cover Wegovy for weight loss?
No, not for weight loss alone. Highmark Wholecare provides Medicaid and Medicare D-SNP coverage in Pennsylvania, which no longer covers GLP-1s for weight loss as of January 2026. Coverage rules are different from Highmark’s commercial plans (such as Highmark Blue Cross Blue Shield). Highmark Wholecare members should check their specific formulary to see whether Wegovy is covered for their situation (such as managing type 2 diabetes or cardiovascular risks) and whether prior authorization or other restrictions apply.
Keep in mind that Medicare Part D has its own rules for weight loss drug coverage, so you shouldn’t assume the commercial Highmark criteria discussed above are the same as a Highmark Wholecare Medicare plan.
Does Highmark cover weight loss drugs?
Some Highmark plans cover weight loss drugs, but the medications covered and requirements for getting them can vary. Depending on your plan, options may include GLP-1 medications such as Wegovy or Zepbound, as well as other FDA-approved weight loss medications.
Check your plan’s formulary or contact Highmark directly to see which weight loss drugs (if any) are covered and whether you’ll need prior authorization. Depending on the weight loss drug, you may also be able to use Ro’s free Insurance Coverage Checker to find out whether your Highmark plan covers treatment.
DISCLAIMER
If you have any medical questions or concerns, please talk to your healthcare provider. The articles on Health Guide are underpinned by peer-reviewed research and information drawn from medical societies and governmental agencies. However, they are not a substitute for professional medical advice, diagnosis, or treatment.
GLP-1 Important Safety Information: Read more about serious warnings and safety info.
Wegovy Important Safety Information: Read more about serious warnings and safety info.
Zepbound Important Safety Information: Read more about serious warnings and safety info.
Foundayo Important Safety Information: Read more about serious warnings and safety info.
References
Alkhouri, N. (2025). Recent data from the ESSENCE trial on semaglutide in metabolic dysfunction-associated steatohepatitis. Gastroenterology & Hepatology, 21(2), 133–135. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11920021/
Canada’s Drug Agency (CDA-AMC). (2025). Reimbursement recommendation: semaglutide (Wegovy). Canadian Journal of Health Technologies, 5(7), 1-29. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK617241/pdf/Bookshelf_NBK617241.pdf
Hernandez, I., Wright, D. R., Guo, J., & Shrank, W. H. (2024). Medicare Part D coverage of anti-obesity medications: a call for forward-looking policy reform. Journal of General Internal Medicine, 39(2), 306–308. doi: 10.1007/s11606-023-08416-9. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC10853087/
Highmark. (2025). GLP-1 Agonist Changes. Retrieved from https://providers.highmark.com/wholecare/wholecare-newsfeed/glp-1-agonist-changes.html
Highmark. (2026-a). Highmark Comprehensive Formulary. Retrieved from https://client.formularynavigator.com/Search.aspx?siteCode=8103967260
Highmark. (2026-b). Highmark Health Insurance Plans for All. Retrieved from https://www.highmark.com/plans
Highmark. (2026-c). Medication Formulary and Exeptions. Retrieved from https://www.highmark.com/wholecare/medicare/benefits-programs/medication-benefits/formulary
Highmark. (2026-d). Pharmacy Policy Bulletin. Retrieved from https://securecms.highmark.com/content/dam/pharmacypolicy/en/highmark/all/policy/J1201-1300/1300/J-1300-002.pdf
Highmark. (2026-e). Welcome to Highmark Wholecare. Retrieved from https://www.highmark.com/wholecare
Highmark. (2026-f). Welcome to My Highmark. Retrieved from https://www.highmark.com/member/member-guide
Novo Nordisk. (2026). Wegovy. Retrieved from https://www.novopricing.com/wegovy.html
Pham, D., Duby, J. J., Setoudeh, S., et al. (2026). Administrative costs of prior authorizations for glucagon-like peptide-1 agonists. Journal of Managed Care & Specialty Pharmacy, 32(3), 292–299. doi: 10.18553/jmcp.2026.32.3.292. Retrieved from https://pubmed.ncbi.nlm.nih.gov/41760565/
Ryan, D. H., Lingvay, I., Deanfield, J., et al. (2024). Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine, 30(7), 2049–2057. doi: 10.1038/s41591-024-02996-7. Retrieved from https://pmc.ncbi.nlm.nih.gov/articles/PMC11271387/
U.S. Food and Drug Administration (FDA). (2026-a). Prescribing Information: Ozempic (semaglutide) injection, for subcutaneous use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/209637Orig1s044lbl.pdf
U.S. Food and Drug Administration (FDA). (2026-b). Prescribing Information: Wegovy (semaglutide) injection, for subcutaneous use; Wegovy (semaglutide) tablets, for oral use. Retrieved from https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf














